Publications by authors named "Johan Nortier"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

569

Total Likes

42

Extended Reach

10,010

Social Features

102
D
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial.
Sonja B Vliek, Iris Noordhoek, Elma Meershoek-Klein Kranenbarg, Annelot G J van Rossum, Vincent O Dezentje, Johan W R Nortier

J Clin Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of Japanese and Dutch women with early breast cancer about monitoring their quality of life.
Rieneke T Lugtenberg, Adrian Kaptein, Ayako Matsuda, Kenichi Inoue, Michael Murray, Johan W R Nortier

J Psychosoc Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.
Stefanie de Groot, Rieneke T Lugtenberg, Danielle Cohen, Marij J P Welters, Ilina Ehsan, Johan W R Nortier

Nat Commun· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
Stefanie de Groot, Hanno Pijl, Ayoub Charehbili, Saskia van de Ven, Vincent T H B M Smit, Johan W R Nortier

Breast Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.
Marloes G M Derks, Cornelis J H van de Velde, Daniele Giardiello, Caroline Seynaeve, Hein Putter, Johan W R Nortier

Oncologist· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Manon M C Komen, Corina J G van den Hurk, Johan W R Nortier, Tjeerd van der Ploeg, P Nieboer

Support Care Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer.
Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, Marjolijn Duijm-de Carpentier, Hein Putter, Johan W R Nortier

Eur J Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer.
Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, Marjolijn Duijm-de Carpentier, Hein Putter, Johan W R Nortier

Breast Cancer Res Treat· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.
Irene L Wapnir, Karen N Price, Stewart J Anderson, André Robidoux, Miguel Martín, Johan W R Nortier

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.
Manon M C Komen, Corina J G van den Hurk, Johan W R Nortier, T van der Ploeg, Carolien H Smorenburg

Eur J Oncol Nurs· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, Marjolijn Duijm-de Carpentier, Hein Putter, Johan W R Nortier

J Natl Cancer Inst· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.
Marloes G M Derks, Erik J Blok, Caroline Seynaeve, Johan W R Nortier, Elma Meershoek-Klein Kranenbarg

Lancet Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.
Irene L Wapnir, Shari Gelber, Stewart J Anderson, Eleftherios P Mamounas, André Robidoux, Johan W R Nortier

Ann Surg Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
Manon M C Komen, Wim P M Breed, Carolien H Smorenburg, Tjeerd van der Ploeg, S H Goey, Johan W R Nortier

Support Care Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stick Together: A Nordic Walking Group Intervention for Breast Cancer Survivors.
Maarten J Fischer, Elly M M Krol-Warmerdam, Gemma M C Ranke, Henricus M Vermeulen, Joke Van der Heijden, Johan W R Nortier

J Psychosoc Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma.
Ab A Aaldriks, Erik J Giltay, Johan W R Nortier, Lydia G M van der Geest, Bea C Tanis

Leuk Lymphoma· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis.
Johanna G H van Nes, Louk V A M Beex, Caroline Seynaeve, Hein Putter, Alexandr Sramek, Johan W R Nortier

Acta Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Wendy Onstenk, Jaco Kraan, Bianca Mostert, Mieke M Timmermans, Ayoub Charehbili, Johan W R Nortier

Mol Cancer Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer.
Jan J Jobsen, Job van der Palen, Mariël Brinkhuis, Johan W R Nortier, Henk Struikmans

Breast Cancer Res Treat· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.
Hans Wouters, Anne M Stiggelbout, Marcel L Bouvy, Gemma A Maatman, Erica C G Van Geffen, Johan W Nortier

Clin Breast Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients--a phase II trial.
Duveken B Y Fontein, Ayoub Charehbili, Johan W R Nortier, Elma Meershoek-Klein Kranenbarg, Judith R Kroep

Eur J Cancer· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines-based diagnostic process does increase hospital delay in a cohort of colorectal cancer patients: a population-based study.
Lydia G M van der Geest, Marloes A G Elferink, Willem Hans Steup, Anne M C Witte, Johan W R Nortier

Eur J Cancer Prev· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial.
Duveken B Y Fontein, Daniel Houtsma, Johan W R Nortier, Renee F Baak-Pablo, Elma Meershoek-Klein Kranenbarg

Breast Cancer Res Treat· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.
Willemien van de Water, Mandy Kiderlen, Esther Bastiaannet, Sabine Siesling, Rudi G J Westendorp, Johan W R Nortier

J Natl Cancer Inst· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis